Hb. Jones et al., MEASURES OF CELL REPLICATION IN RISK SAFETY ASSESSMENT OF XENOBIOTIC-INDUCED, NONGENOTOXIC CARCINOGENESIS/, Regulatory toxicology and pharmacology, 23(2), 1996, pp. 117-127
The phenomena associated with nongenotoxic carcinogenesis are multifac
eted and complex. Nongenotoxic carcinogens stimulate cell replication
in the presence or the absence of cytotoxicity. Cell proliferation is
pivotal in the neoplastic process, but the extent of its contribution
to the development of xenobiotic-induced cancer remains an open questi
on. The search for a better understanding of this process has generate
d considerable interest and effort, often with the objective of obtain
ing useful predictors of the tumourigenic potential of xenobiotics. Al
terations in the natural balance of endogenous humoural agents that ma
intain replicative homeostasis results in proliferative stimulation (o
r inhibition) which may be transient or sustained. The bases for the m
olecular interaction of these mediators with cellular receptors, trans
-cytoplasmic message conveyance, and subsequent nuclear responses lead
ing to xenobiotic-induced mitosis are becoming better understood. Asse
ssment of tissue replicative status has now become established and uti
lizes biochemical and histological methodology in a routine manner. Th
e increasingly challenging international regulatory environment is dem
anding greater understanding of the mechanisms that underlie fundament
al phenomena and the influences exerted by xenobiotics prior to their
registration. While the precise mode of action of an individual xenobi
otic may not be known, sound interpretation of toxicological data, inc
luding the contribution made by cell replication, creates greater conf
idence of its safety in the scientific, regulatory, and commercial com
munities. This article offers a view of cell proliferation from molecu
lar interactions at the cellular level, through practical assessment o
f cell and tissue replicative status to its utility in contributing to
the registration of new drugs and chemicals. (C) 1996 Academic Press,
Inc.